Incline Equity Partners and portfolio company Wheaton Industries Inc. (“Wheaton”) announced today the acquisition of CELLine, a division of Wilson Wolf Manufacturing Corporation that manufactures disposable cell culture flasks.

This is the second add-on acquisition for Wheaton Industries since Incline’s initial investment in June 2010. In February 2011, Wheaton acquired Laboratory Sales Limited (LSL) in Manchester, England.

CELLine flasks are dual membrane cell culture devices used in small scale antibody and protein production. The product line is recognized by leading scientists worldwide for its ease of use and laboratory productivity.

“This acquisition reflects our commitment to enhancing value at Wheaton through acquisitions,” said Jack Glover, Partner of Incline Equity Partners and Wheaton director. “The CELLine portfolio augments Wheaton’s position in the growing market of cell culture tools used in the life science industries.”

About Incline Equity Partners
Incline Equity Partners, headquartered in Pittsburgh, Pennsylvania, is a private equity firm focused on making investments in lower middle-market growth companies, focusing on companies with enterprise values of $30MM to $125MM across a variety of industry sectors including value-added distribution, specialized light manufacturing and business and industrial services. Typical investment types are management buyouts, ownership transitions for privately held businesses and corporate divestitures. Incline Equity Partners has experience with investing, mergers and acquisitions, leveraged finance, leveraged buyouts and growth capital.

Incline Management Corporation (“IMC”) is registered with the U.S. Securities and Exchange Commission as an investment adviser under the U.S. Investment Advisers Act of 1940, as amended.  Registration as an investment adviser does not imply a certain level of skill or training.  IMC provides investment advisory services only to privately offered funds.  IMC does not solicit or make its services available to the public or other advisory clients.  This press release is intended solely to provide information regarding Incline’s potential capabilities for prospective portfolio companies, and is not an offer to sell to any person, or a solicitation from any person of an offer to buy, any securities.  The statements contained herein are not statements of any IMC client fund or investor and do not describe any experience with or endorsement of IMC as an investment adviser by any such client or investor.